Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 10;24(14):2263-70.
doi: 10.1097/QAD.0b013e32833d45c5.

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

Collaborators, Affiliations

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

Morna Cornell et al. AIDS. .

Abstract

Objective: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, loss-to-follow-up (LTFU) and retention] over time in a network of South African ART cohorts.

Design: Cohort analysis utilizing routinely collected patient data.

Methods: Analysis included adults initiating ART in eight public sector programmes across South Africa, 2002-2007. Follow-up was censored at the end of 2008. Kaplan-Meier methods were used to estimate time to outcomes, and proportional hazards models to examine independent predictors of outcomes.

Results: Enrolment (n = 44 177, mean age 35 years; 68% women) increased 12-fold over 5 years, with 63% of patients enrolled in the past 2 years. Twelve-month mortality decreased from 9% to 6% over 5 years. Twelve-month LTFU increased annually from 1% (2002/2003) to 13% (2006). Cumulative LTFU increased with follow-up from 14% at 12 months to 29% at 36 months. With each additional year on ART, failure to retain participants was increasingly attributable to LTFU compared with recorded mortality. At 12 and 36 months, respectively, 80 and 64% of patients were retained.

Conclusion: Numbers on ART have increased rapidly in South Africa, but the programme has experienced deteriorating patient retention over time, particularly due to apparent LTFU. This may represent true loss to care, but may also reflect administrative error and lack of capacity to monitor movements in and out of care. New strategies are needed for South Africa and other low-income and middle-income countries to improve monitoring of outcomes and maximize retention in care with increasing programme size.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan-Meier plots showing by year of ART initiation: (a) 60-month mortality, (b) 60-month loss-to-follow-up, (c) 60-month programme retention

Similar articles

Cited by

References

    1. World Health Organization, UNAIDS, UNICEF. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report. Geneva: WHO; 2007.
    1. Department of Health. Progress Report on Declaration of Commitment on HIV and AIDS: Republic of South Africa: Reporting Period: January 2006 – December 2007. 2008.
    1. Cornell M, Technau K, Fairall LR, Wood R, Moultrie H, Van Cutsem G, et al. Monitoring the South African National Antiretroviral Treatment Programme, 2003 – 2007: The IeDEA Southern Africa Collaboration. South African Medical Journal. 2009. pp. 653–660. Full text available at: http://www.samj.org.za/index.php/samj/article/viewFile/3437/2485. - PMC - PubMed
    1. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Aids. 2008;22:1897–1908. - PMC - PubMed
    1. Zachariah R, Harries K, Moses M, Manzi M, Line A, Mwagomba B, Harries AD. Very early mortality in patients starting antiretroviral treatment aqt primary health centres in rural Malawi. Trop Med Int Health. 2009;14:713–721. - PubMed

Publication types

Substances